Figure 1.
Early hormonal therapy administered at prostate-specific antigen <10 ng ml−1 affects clinical metastasis-free survival. Patients with pathological Gleason Sum > 7 or PSA-DT < 12 months. Used with permission from Moul et al18.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.